Ronald K. Lloyd

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Hazelwood, MO
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Jeffrey Hamet, Attorney-in-Fact for Ronald K. Lloyd
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Ronald K. Lloyd

Form 4 holding PRESIDENT AND CEO, Director

AZIYO BIOLOGICS, INC.

Security class
Restricted Stock Units
Shares / value
39,894
Estimated value
$96,145
Report date
08 Mar 2022
Price
$2.41
Ownership
Direct
Underlying class
Class A Common Stock
Underlying amount
Form 4 holding PRESIDENT AND CEO, Director

AZIYO BIOLOGICS, INC.

Security class
Class A Common Stock
Shares / value
31,775
Estimated value
$76,578
Report date
08 Mar 2022
Price
$2.41
Ownership
Direct
Form 4 holding PRESIDENT AND CEO, Director

AZIYO BIOLOGICS, INC.

Security class
Stock Option (Right to Buy)
Shares / value
138,770
Estimated value
Report date
08 Mar 2022
Price
Ownership
Direct
Underlying class
Class A Common Stock
Underlying amount

Insider Reports Filed by Ronald K. Lloyd

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .